Company Filing History:
Years Active: 2023
Title: Qingyan Li: Innovator in Chimeric Antibody Technology
Introduction
Qingyan Li is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antibodies. His innovative work has the potential to advance therapeutic strategies in immunology.
Latest Patents
Qingyan Li holds a patent for a chimeric antibody immune effector cell engager. This invention includes a target cell binding domain that specifically binds to an antigen on a target cell, along with an immune effector cell binding domain that comprises an antigen-binding fragment. The patent also encompasses pharmaceutical compositions, kits, and methods of treatment, showcasing the versatility and applicability of his invention.
Career Highlights
Qingyan Li is associated with Nanjing Legend Biotech Co., Ltd., where he continues to push the boundaries of research and development in biotechnology. His work is characterized by a commitment to innovation and excellence in the field.
Collaborations
He collaborates with notable colleagues, including Xiaohu Fan and Qiuchuan Zhuang, who contribute to the advancement of their shared research goals.
Conclusion
Qingyan Li's contributions to chimeric antibody technology exemplify the impact of innovative thinking in biotechnology. His work not only enhances our understanding of immune responses but also paves the way for new therapeutic approaches.